☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
AHA
Amgen to Present Long-Term Safety-Efficacy Data of Repatha (evolocumab) in Multiple studies- at AHA 2018
November 6, 2018
Innovent Presents P-III (CREDIT-1) Trial Results of Tafolecimab for Non-Familial Hypercholesterolemia at AHA 2022
November 7, 2022
Amarin Publishes Results of Vascepa (icosapent ethyl) in (REDUCE-IT) Study for the Treatment of Cardiovascular Diseases in JAHA 20...
March 11, 2022
BioMarin Presents 2-Year Analysis of Valoctocogene Roxaparvovec in P-III (GENEr8-1) Study for Severe Hemophilia A at EAHAD 2022
February 7, 2022
CSL Behring Presents Results of Etranacogene Dezaparvovec in P-III (HOPE-B) Trial for the Treatment of Hemophilia B at EAHAD 2022
February 7, 2022
PharmaShots Interview: Recce Pharmaceuticals' James Graham Shares Insight on the P-I/II Clinical Trial of RECCE 327 (R327) for Inf...
September 14, 2021
PharmaShots Interview: Medicenna's Dr. Fahar Merchant Shares Insights on the Bispecific Superkines
May 26, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.